Biotechnology company Cyclana Bio has raised £5 million ($6.7 million) to advance its drug discovery for endometriosis. The pre-seed funding round was co-led by NfX and Eka VC, with investors including Cocoa VC, Wilbe, and Angel investors. Cyclana Bio aims to use the investment to develop both functional disease models and its platform investigating tissue […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!